Skip to content

Drug interactions

Imipramine + Octreotide

Severity: Moderate

Imipramine and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Octreotide can cause bradycardia and QT prolongation, which may add to the QT effect of imipramine. The risk is greatest with bradycardia, electrolyte disturbance or heart disease.

What this interaction means in plain words

Imipramine and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imipramine belongs to Central Nervous System; Octreotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive QT prolongation, with octreotide-related bradycardia increasing arrhythmia susceptibility.

What to do

Check baseline ECG and electrolytes and monitor heart rate and QTc during treatment, especially in patients with cardiac disease.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imipramine and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imipramine with Octreotide?

MediHelp rates the interaction as moderate. Imipramine and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide can cause bradycardia and QT prolongation, which may add to the QT effect of imipramine. The risk is greatest with bradycardia, electrolyte disturbance or heart disease.

How serious is the interaction between Imipramine and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline ECG and electrolytes and monitor heart rate and QTc during treatment, especially in patients with cardiac disease.

What other medicines interact with Imipramine?

MediHelp also lists interactions of Imipramine with, for example, Dronedarone, Isocarboxazid, Phenelzine. The full list is on the Imipramine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in